TIGAR and cervical carcinoma: Here we demonstrate that the TIGAR protein is highly expressed in primary hrHPV+ cervical carcinoma clinical isolates, and that the siRNA-inhibition of TIGAR expression hypersensitizes HPV18-transformed HeLa cervical adenocarcinoma cells to low-dose concentrations of genotoxic chemotherapy drugs that cause oxidative stress and DNA-damage.